Clinical potential of miRNA-221 as a novel prognostic biomarker for hepatocellular carcinoma.
about
Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasisPrognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis.Role of microRNAs in the main molecular pathways of hepatocellular carcinoma.The Role of MicroRNAs in Hepatocellular Carcinoma
P2860
Clinical potential of miRNA-221 as a novel prognostic biomarker for hepatocellular carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Clinical potential of miRNA-22 ...... for hepatocellular carcinoma.
@en
type
label
Clinical potential of miRNA-22 ...... for hepatocellular carcinoma.
@en
prefLabel
Clinical potential of miRNA-22 ...... for hepatocellular carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Clinical potential of miRNA-22 ...... for hepatocellular carcinoma.
@en
P2093
Dong-Sheng Fu
Jian-Guo Huang
Shun-E Yang
Xin-Feng Li
P2860
P304
P356
10.3233/CBM-161671
P577
2016-12-09T00:00:00Z